A 1 LYS 15 -11.302 -11.727
A 2 LEU 2 -12.737 -11.502
A 3 CYS 13 -14.777 -14.573
A 4 SER 1 -12.587 -11.254
A 5 LEU 5 -12.280 -11.443
A 6 ASP 4 -12.499 -11.521
A 7 ASN 13 -14.993 -14.764
A 8 GLY 22 -15.439 -16.194
A 9 ASP 8 -14.840 -14.054
A 10 CYS 23 -16.995 -17.685
A 11 ASP 18 -15.716 -15.978
A 12 GLN 17 -16.147 -16.245
A 13 PHE 12 -16.849 -16.292
A 14 CYS 16 -17.461 -17.293
A 15 HIS 9 -15.463 -14.720
A 16 GLU 9 -12.844 -12.402
A 17 GLU 8 -10.710 -10.398
A 18 GLN 0 -6.904 -6.110
A 19 ASN 0 -8.074 -7.146
A 20 SER 5 -11.387 -10.653
A 21 VAL 21 -14.130 -14.920
A 22 VAL 7 -16.072 -15.028
A 23 CYS 21 -17.651 -18.036
A 24 SER 7 -16.878 -15.742
A 25 CYS 21 -16.426 -16.952
A 26 ALA 9 -15.179 -14.468
A 27 ARG 2 -11.777 -10.652
A 28 GLY 8 -10.231 -9.975
A 29 TYR 20 -12.982 -13.789
A 30 THR 5 -13.493 -12.516
A 31 LEU 14 -15.147 -15.015
A 32 ALA 10 -13.672 -13.250
A 33 ASP 0 -11.735 -10.385
A 34 ASN 9 -12.369 -11.981
A 35 GLY 8 -14.446 -13.705
A 36 LYS 12 -15.713 -15.286
A 37 ALA 6 -15.219 -14.159
A 38 CYS 24 -16.104 -17.012
A 39 ILE 7 -13.150 -12.443
A 40 PRO 9 -9.991 -9.877
A 41 THR 9 -9.021 -9.018
A 42 GLY 7 -6.089 -6.194
A 43 PRO 3 -4.890 -4.673
A 44 TYR 4 -5.780 -5.576
A 45 PRO 13 -8.375 -8.907
A 46 CYS 9 -9.138 -9.122
A 47 GLY 12 -9.165 -9.491
A 48 LYS 15 -7.215 -8.110
A 49 GLN 2 -3.103 -2.976 <=B
A 50 THR 6 -1.906 -2.377 <=B
A 51 LEU 0 -0.992 -0.878 <=B
A 52 GLU 2 0.372 0.100 <=B

Identified 4 B-Cell epitope residues out of 52 total residues